Cáncer de tiroides en nódulo hipercaptante por gammagrafía. Serie de casos.
Resumo
La presencia de nódulos tiroideos es una condición clínica de alta prevalencia en la población general.Cuando gammagráficamente son hipercaptantes a menudo se considera como una condición benigna;sin embargo, a pesar de presentarse esta condición, cuando la clínica es sugestiva de malignidad, es recomendado la realización de un estudio histológico. En este artículo se presentan tres casos en los que la clínica nos hizo sospechar de malignidad y se confirmó con estudios histológicos posteriores.Downloads
Referências
Bui A, Mazzaferri E L. New Paradigms in the Diagnosis andManagement of Thyroid Nodules. The Endocrinologist.2007;17(1):35-45.
Tan G H, Gharib H. Thyroid Incidentalomas: ManagementApproaches to Nonpalpable Nodules Discovered Incidentallyon Thyroid Imaging. Ann Intern Med. 1997;126:226-231.
Bommireddipalli S. Follicular Variant of Papillary Thyroid CarcinomaPresenting as a Toxic Nodule by I-123 Scintigraphy ,Clinical Nuclear Medicine. 2010;35(10):770-5.
Leenhardt L, Bernier M O, Boin-Pineau M H. Advances inDiagnostic Practices Affect Thyroid Cancer Incidence in France.Eur J Endocrinol. 2004;150:133-9.
Rosário P W. Contribution of Scintigraphy and Ultrasonographyto the Prediction of Malignancy in Thyroid Nodules with IndeterminateCytology. Arq Bras Endocrinol Metab. 2010;54(1):56-9.
Ashcraft M W, Van Herle A J. Management of Thyroid Nodules.II. Scanning Techniques, Thyroid Suppressive Therapy, and FineNeedle Aspiration. Head Neck Surg. 1981;3:297-322.
Niepomniszcze H, Suarez H, Pitoia F. Case Reports: FollicularCarcinoma Presenting as Autonomous Functioning ThyroidNodule and Containing an Activating Mutation of the TSHReceptor (T620I) and a Mutation of the Ki-RAS (G12C) genes.Thyroid. 2006;16:497-503.
Ross D S. Diagnostic Approach to and Treatment of ThyroidNodules. I. In: Rose B D, ed. UpToDate. Wellesley, M A: UpTo-Date. Last accessed December 2008.
Marc D C. Evaluation and Imaging of a Thyroid Nodule. SurgOncol Clin N Am. 2008;17:37-56.
Singer P A, Cooper D S, Daniels G H. Treatment Guidelines forPatients with Thyroid Nodules and Well-differentiated ThyroidCancer. Arch Intern Med. 1996;156:2165-72.
Mazzaferri E L. Management of a Thyroid Solitary Nodule. NEngl J Med. 1993;328:553-9.
Wong C K, Wheeler M H. Thyroid Nodules: Rational Management.World J Surg. 2000;24:934-41.
Cakir M, Arici C, Alakus H. Incidental Thyroid Carcinoma inThyrotoxic Patients Treated by Surgery. Horm Res. 2007;67:96-9.
McCaffrey T V. Evaluation of the Thyroid Nodule. CancerControl. 2000;7:223-8.
Cooper D S, Doherty G M, Haugen B R. Management Guidelinesfor Patients with Thyroid Nodules and DifferentiatedThyroid Cancer: The American Thyroid Association GuidelinesTaskforce. Thyroid. 2006;16:109-42.
Ragni F, Pinelli D, Facchini M. Thyroid Carcinoma in HyperthyroidSyndromes in Italian. G Chir. 1996;17:158-165.
Meller J, Becker W. The Continuing Importance of ThyroidScintigraphy in the Era of High-resolution Ultrasound. Eur JNucl Med Mol Imaging. 2002;29(2):425-38.
Horvath E, Majlis S, Rossi R. An Ultrasonogram ReportingSystem for Thyroid Nodules Stratifying Cancer Risk for ClinicalManagement. J Clin Endocrinol Metab. 2009;94:1748-51.
